LINC00511 and breast cancer: These in vivo clinical results are consistent with a previous in vitro study (30), suggesting that LINC00511 uses as a serum molecular biomarker for BC diagnosis, and contributing to downstream genes transcriptional regulation as well as an increased BC cell growth and expression.